Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-14 Costa Paulo F Director Grant or award · Stock Option (right to buy) +15,000 15,000
2020-05-06 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +500 $0.94 $470 44,968
2020-05-06 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +7,532 $1.51 $11K 52,500
2020-05-06 Risser Eric Blasius Sr VP & Chief Business Officer Sale −500 $10.00 $5K 52,000
2020-05-06 Risser Eric Blasius Sr VP & Chief Business Officer Sale −1,000 $15.00 $15K 51,000
2020-05-06 Risser Eric Blasius Sr VP & Chief Business Officer Sale −3,000 $20.00 $60K 48,000
2020-05-06 Risser Eric Blasius Sr VP & Chief Business Officer Sale −3,532 $25.00 $88K 44,468
2020-05-06 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −500 $0.94 $470 1,489
2020-05-06 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −7,532 $1.51 $11K 19,100
2020-04-16 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +6,000 $0.94 $6K 44,468
2020-04-16 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −6,000 $0.94 $6K 1,989
2020-03-13 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +6,000 $0.94 $6K 38,468
2020-03-13 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −6,000 $0.94 $6K 500
2020-03-11 Koenig Scott President and CEO Exercise or conversion +133,163 $0.94 $125K 943,103
2020-03-11 Koenig Scott President and CEO Exercise or conversion · Employee stock option (right to buy) −133,163 0
2020-03-06 Karrels James SVP, CFO and Secretary Exercise or conversion +4,473 $0.94 $4K 152,460
2020-03-06 Karrels James SVP, CFO and Secretary Exercise or conversion · Employee stock option (right to buy) −4,473 1,000
2020-02-20 Bonvini Ezio Sr VP, Research & CSO Grant or award · Employee stock option (right to buy) +100,000 $11.50 $1.1M 100,000
2020-02-20 Cilinski Lynn VP, Controller and Treasurer Grant or award · Employee stock option (right to buy) +35,000 $11.50 $403K 35,000
2020-02-20 Karrels James SVP, CFO and Secretary Grant or award · Employee stock option (right to buy) +90,000 $11.50 $1.0M 90,000

Page 27 of 35 · 684 trades